Galectin Therapeutics Inc SEC filings GALT
Galectin Therapeutics Inc has 1,000 filings in SEC EDGAR's recent list, going back to Oct 18, 2011. Its latest annual report, Form ARS, was filed on Oct 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 14, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Oct 13, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Oct 22, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Dec 3, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 29, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | Oct 6, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 30, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 31, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 31, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Mar 16, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Mar 6, 2019 | Dec 31, 2018 |
| 10-K/A | Amended annual report | Sep 28, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Mar 29, 2018 | Dec 31, 2017 |
| 10-K/A | Amended annual report | Apr 28, 2017 | Dec 31, 2016 |
| 10-K | Annual report | Mar 28, 2017 | Dec 31, 2016 |
| 10-K/A | Amended annual report | Apr 29, 2016 | Dec 31, 2015 |
| 10-K | Annual report | Mar 15, 2016 | Dec 31, 2015 |
| 10-K | Annual report | Mar 18, 2015 | Dec 31, 2014 |
| 10-K | Annual report | Mar 21, 2014 | Dec 31, 2013 |
| 10-K | Annual report | Mar 29, 2013 | Dec 31, 2012 |
| 10-K | Annual report | Mar 30, 2012 | Dec 31, 2011 |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GALT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Norcross, GA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1133416
- Former names
- PRO PHARMACEUTICALS INC (until May 26, 2011)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.